Mason Hawkins
Hawkins reshuffled Q2 2026 holdings: opened ABT, trimmed FDX for 4th quarter, positioned against AI rally.
- Trimmed FDX for a 4th consecutive quarter
- Trimmed SN for a 4th consecutive quarter
- New $76.3M position in ABT
Sources & details
Windowpast 90 days · 17 events · ending Sep 11, 2026
DetailTrimmed FDX for a 4th consecutive quarter (−52.7k shares in 2026-Q2) · Trimmed SN for a 4th consecutive quarter (−187.4k shares in 2026-Q2) · New $76.3M position in ABT — 4% of portfolio · Trimmed FDX by $27.1M — 1% of portfolio, −21% QoQ · Trimmed RYN by $19.9M — 1% of portfolio, −12% QoQ
Full summary
Mason Hawkins disclosed a broad rebalancing in Q2 2026, marked by a new $76.3M position in Abbott Laboratories (ABT, ≈4% of disclosed book) alongside systematic trimming across multiple holdings. The quarter reflected Hawkins's stated deep-value thesis, deliberately positioned against the AI-driven melt-up and betting on company-specific catalysts and eventual mean reversion after a bruising year. The largest reduction came in FDX, which Hawkins trimmed for a 4th consecutive quarter (−52.7k shares, −$27.1M) — the largest reduction in FDX on record with us since 2025-Q2. He also trimmed SN for a 4th consecutive quarter (−187.4k shares, −$16.9M, −75% QoQ), alongside cuts to TRIP (−2.3M shares, −51% QoQ), RYN (−1.3M shares, −12% QoQ), and smaller trims to PPLI, MGM, HTHT, KHC, DOLE, and MICC. Offsetting these exits, Hawkins added to AVTR (+1.2M shares, +34% QoQ, ≈1% of portfolio), ACI (+1.2M shares, +16% QoQ), SAM (+27.6k shares, +23% QoQ), REGN (+21.7k shares, +17% QoQ), and CLW (+14.1k shares). The pattern across the window—deep cuts to cyclical and travel-linked names paired with selective adds in healthcare and specialty names—aligns with Hawkins's stated positioning: a concentrated, contrarian bet on value and mean reversion in a market dominated by AI enthusiasm.
Underlying filings
- Institutional holdingMason HawkinsJun 30, 2026Trimmed SN · −187.4k shares · −$16.9M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed PPLI · −890.9k shares · −$16.5M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed HTHT · −25.7k shares · −$3.1M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed MGM · −493.4k shares · −$5.6M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed RYN · −1.3M shares · −$19.9M
- Institutional holdingMason HawkinsJun 30, 2026Added to REGN · +21.7k shares · −$6.0M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed TRIP · −2.3M shares · −$18.1M
- Institutional holdingMason HawkinsJun 30, 2026Added to CLW · +14.1k shares · +$2.2M
- Institutional holdingMason HawkinsJun 30, 2026Added to AVTR · +1.2M shares · +$19.2M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed KHC · −340.8k shares · −$3.6M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed FDX · −52.7k shares · −$27.1M
- Institutional holdingMason HawkinsJun 30, 2026Added to ACI · +1.2M shares · −$9.6M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed DOLE · −181.6k shares · −$3.6M
- Institutional holdingMason HawkinsJun 30, 2026Trimmed MICC · −618.0k shares · −$6.8M
- Institutional holdingMason HawkinsJun 30, 2026Added to SAM · +27.6k shares · −$1.4M
- Institutional holdingMason HawkinsJun 30, 2026Opened position in ABT · 840.7k shares · $76.3M
Source8 citations →
GeneratedSep 11, 2026
NoteAuto-generated summary · not investment advice · verify before acting.